Brief: Diamyd Medical Updates On Booster Trial With Diamyd®
20/10/2023 10:16
Oct 20 (Reuters) - Diamyd Medical AB DMYDb.ST :
* PRELIMINARY RESULTS FROM BOOSTER TRIAL WITH DIAMYD®
PROVIDE
ADDITIONAL SUPPORT FOR INTRALYMPHATIC INJECTIONS
* SHOWING ONLY A SMALL DECLINE IN STIMULATED ENDOGEOUS
INSULIN
PRODUCTION ONE YEAR FOLLOWING ADDITIONAL INJECTION AND UP TO 8
YEARS FROM TYPE 1 DIABETES DIAGNOSIS
Source text for Eikon: ID:nWkr7GgpZc
Further company coverage: DMYDb.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))